UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmaceuticals in the aquatic environment––a comparison of risk assessment strategies

Chemosphere (Oxford), 2004-09, Vol.56 (11), p.1143-1155

2004

Volltextzugriff (PDF)

A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes

Diabetes care, 2016-04, Vol.39 (4), p.511-517

2016

Volltextzugriff (PDF)

Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans

Diabetes, obesity & metabolism, 2013-05, Vol.15 (5), p.474-477

2013

Volltextzugriff (PDF)

Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans

The American journal of clinical nutrition, 2012-01, Vol.95 (1), p.78-83

2012

Volltextzugriff (PDF)

Effects of Taurocholic Acid on Glycemic, Glucagon-like Peptide-1, and Insulin Responses to Small Intestinal Glucose Infusion in Healthy Humans

The journal of clinical endocrinology and metabolism, 2013-04, Vol.98 (4), p.E718-E722

2013

Volltextzugriff (PDF)

Household Disposal of Pharmaceuticals as a Pathway for Aquatic Contamination in the United Kingdom

Environmental health perspectives, 2005-12, Vol.113 (12), p.1705-1711

2005

Volltextzugriff (PDF)

Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: Stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?

Diabetes research and clinical practice, 2014-10, Vol.106 (1), p.e3-e6

2014

Volltextzugriff (PDF)

Use of Census-based Aggregate Variables to Proxy for Socioeconomic Group: Evidence from National Samples

American journal of epidemiology, 1998-09, Vol.148 (5), p.475-486

1998

Volltextzugriff (PDF)

Accounting for the Black-White Wealth Gap: A Nonparametric Approach

Journal of the American Statistical Association, 2002-09, Vol.97 (459), p.663-673

2002

Volltextzugriff (PDF)

Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial

Nutrition (Burbank, Los Angeles County, Calif.), 2016-05, Vol.32 (5), p.553-559

2016

Volltextzugriff (PDF)

Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes

Diabetes & vascular disease research, 2017-01, Vol.14 (1), p.59-63

2017

Volltextzugriff (PDF)

Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial

The American journal of clinical nutrition, 2016-01, Vol.103 (1), p.66-70

2016

Volltextzugriff (PDF)

Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study

Diabetologia, 2024-07, Vol.67 (7), p.1260-1270

2024

Volltextzugriff (PDF)

Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial

Diabetes care, 2020-08, Vol.43 (8), p.1813-1821

2020

Volltextzugriff (PDF)

Changes in the Structure of Wages in the 1980's: An Evaluation of Alternative Explanations

The American economic review, 1992-06, Vol.82 (3), p.371-392

1992

Volltextzugriff (PDF)

Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes

Diabetes, obesity & metabolism, 2024-09, Vol.26 (9), p.3897-3905

2024

Volltextzugriff (PDF)

Title: Differentiating the effects of whey protein and guar gum preloads on postprandial glycemia in type 2 diabetes

Clinical nutrition (Edinburgh, Scotland), 2019-12, Vol.38 (6), p.2827-2832

2019

Volltextzugriff (PDF)

Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?

Diabetic medicine, 2015-05, Vol.32 (5), p.595-600

2015

Volltextzugriff (PDF)

A whey/guar “preload” improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12‐week, single‐blind, randomized, placebo‐controlled trial

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.930-938

2019

Volltextzugriff (PDF)

The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial

Diabetes (New York, N.Y.), 2016-01, Vol.65 (1), p.269-275

2016

Volltextzugriff (PDF)

Effects of Sitagliptin on Glycemia, Incretin Hormones, and Antropyloroduodenal Motility in Response to Intraduodenal Glucose Infusion in Healthy Lean and Obese Humans and Patients With Type 2 Diabetes Treated With or Without Metformin

Diabetes (New York, N.Y.), 2014-08, Vol.63 (8), p.2776-2787

2014

Volltextzugriff (PDF)

Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 Diabetes

Diabetes care, 2017-05, Vol.40 (5), p.702-705

2017

Volltextzugriff (PDF)

Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans

Diabetes care, 2013-12, Vol.36 (12), p.e202-e203

2013

Volltextzugriff (PDF)

Systems mapping workshops and their role in understanding medication errors in healthcare

Applied ergonomics, 2010-09, Vol.41 (5), p.645-656

2010

Volltextzugriff (PDF)

Effects of a D-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes

Diabetes care, 2013-07, Vol.36 (7), p.1913-1918

2013

Volltextzugriff (PDF)

1 – 25 von 345

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(225)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(344)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(144)
Humans
(100)
Female
(63)
Male
(52)
Biological And Medical Sciences
(50)
Adult
(38)
Agriculture
(38)
Social Sciences
(36)
Middle Aged
(35)
Fundamental And Applied Biological Sciences. Psychology
(29)
Aged
(26)
General & Internal Medicine
(25)
Medicine, General & Internal
(25)
Adolescent
(24)
Business & Economics
(24)
Usa
(24)
Economics
(23)
Endocrinology & Metabolism
(23)
Medical Sciences
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmaceuticals in the aquatic environment––a comparison of risk assessment strategies

A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes

Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans

Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans

Effects of Taurocholic Acid on Glycemic, Glucagon-like Peptide-1, and Insulin Responses to Small Intestinal Glucose Infusion in Healthy Humans

Household Disposal of Pharmaceuticals as a Pathway for Aquatic Contamination in the United Kingdom

Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: Stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?

Use of Census-based Aggregate Variables to Proxy for Socioeconomic Group: Evidence from National Samples

Accounting for the Black-White Wealth Gap: A Nonparametric Approach

Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial

Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes

Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial

Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study

Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial

Changes in the Structure of Wages in the 1980's: An Evaluation of Alternative Explanations

Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes

Title: Differentiating the effects of whey protein and guar gum preloads on postprandial glycemia in type 2 diabetes

Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?

A whey/guar “preload” improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12‐week, single‐blind, randomized, placebo‐controlled trial

The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial

Effects of Sitagliptin on Glycemia, Incretin Hormones, and Antropyloroduodenal Motility in Response to Intraduodenal Glucose Infusion in Healthy Lean and Obese Humans and Patients With Type 2 Diabetes Treated With or Without Metformin

Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 Diabetes

Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans

Systems mapping workshops and their role in understanding medication errors in healthcare

Effects of a D-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes

Suchergebnisse filtern